Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Active Pharmaceutical Ingredients Market Report 2019, Competitive Landscape, Trends and Opportunities

  • MAI3216810
  • 136 Pages
  • July 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Active Pharmaceutical Ingredients market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Active Pharmaceutical Ingredients market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Active Pharmaceutical Ingredients market.

Major players in the global Active Pharmaceutical Ingredients market include:

Johnson & Johnson

Sanofi

Eli Lilly and Company

Bristol-Myers Squibb

AbbVie

Haerbin Pharmaceutical Group

Shandong Xinhua Pharmaceutical

Jiangsu Hengrui Medicine

Merck & Co

Biocon

Boehringer Ingelheim

Huahai Pharmaceutical

Sun Pharmaceutical Industries

DSM

Shandong Lukang Pharmaceutical

Teva Pharmaceutical

Lonza Group

Aurobindo Pharma

Pfizer

GlaxoSmithKline

Lupin

Hisun Pharmacy

North China Pharmaceutical Group

Novartis International

Bayer

On the basis of types, the Active Pharmaceutical Ingredients market is primarily split into:

Synthetic APIs

Biotech APIs

On the basis of applications, the market covers:

Oncology

Diabetes

Cardiovascular Disease

CNS and Neurological Disorders

Endocrinology

Other

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Active Pharmaceutical Ingredients market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Active Pharmaceutical Ingredients market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Active Pharmaceutical Ingredients industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Active Pharmaceutical Ingredients market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Active Pharmaceutical Ingredients, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Active Pharmaceutical Ingredients in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Active Pharmaceutical Ingredients in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Active Pharmaceutical Ingredients. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Active Pharmaceutical Ingredients market, including the global production and revenue forecast, regional forecast. It also foresees the Active Pharmaceutical Ingredients market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

Table of Contents

1 Active Pharmaceutical Ingredients Market Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients

1.2 Active Pharmaceutical Ingredients Segment by Type

1.2.1 Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Synthetic APIs

1.2.3 The Market Profile of Biotech APIs

1.3 Global Active Pharmaceutical Ingredients Segment by Application

1.3.1 Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Oncology

1.3.3 The Market Profile of Diabetes

1.3.4 The Market Profile of Cardiovascular Disease

1.3.5 The Market Profile of CNS and Neurological Disorders

1.3.6 The Market Profile of Endocrinology

1.3.7 The Market Profile of Other

1.4 Global Active Pharmaceutical Ingredients Market by Region (2014-2026)

1.4.1 Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3 Europe Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.1 Germany Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.2 UK Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.3 France Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.4 Italy Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.5 Spain Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.6 Russia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.3.7 Poland Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.4 China Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.5 Japan Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.6 India Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.8 Central and South America Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Active Pharmaceutical Ingredients (2014-2026)

1.5.1 Global Active Pharmaceutical Ingredients Revenue Status and Outlook (2014-2026)

1.5.2 Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)

2 Global Active Pharmaceutical Ingredients Market Landscape by Player

2.1 Global Active Pharmaceutical Ingredients Production and Share by Player (2014-2019)

2.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Player (2014-2019)

2.3 Global Active Pharmaceutical Ingredients Average Price by Player (2014-2019)

2.4 Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Active Pharmaceutical Ingredients Market Competitive Situation and Trends

2.5.1 Active Pharmaceutical Ingredients Market Concentration Rate

2.5.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Johnson & Johnson

3.1.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.1.3 Johnson & Johnson Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.1.4 Johnson & Johnson Business Overview

3.2 Sanofi

3.2.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.2.3 Sanofi Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.2.4 Sanofi Business Overview

3.3 Eli Lilly and Company

3.3.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.3.3 Eli Lilly and Company Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.3.4 Eli Lilly and Company Business Overview

3.4 Bristol-Myers Squibb

3.4.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.4.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.4.4 Bristol-Myers Squibb Business Overview

3.5 AbbVie

3.5.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.5.3 AbbVie Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.5.4 AbbVie Business Overview

3.6 Haerbin Pharmaceutical Group

3.6.1 Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.6.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.6.4 Haerbin Pharmaceutical Group Business Overview

3.7 Shandong Xinhua Pharmaceutical

3.7.1 Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.7.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.7.4 Shandong Xinhua Pharmaceutical Business Overview

3.8 Jiangsu Hengrui Medicine

3.8.1 Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.8.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.8.4 Jiangsu Hengrui Medicine Business Overview

3.9 Merck & Co

3.9.1 Merck & Co Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.9.3 Merck & Co Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.9.4 Merck & Co Business Overview

3.10 Biocon

3.10.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.10.3 Biocon Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.10.4 Biocon Business Overview

3.11 Boehringer Ingelheim

3.11.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.11.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.11.4 Boehringer Ingelheim Business Overview

3.12 Huahai Pharmaceutical

3.12.1 Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.12.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.12.4 Huahai Pharmaceutical Business Overview

3.13 Sun Pharmaceutical Industries

3.13.1 Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.13.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.13.4 Sun Pharmaceutical Industries Business Overview

3.14 DSM

3.14.1 DSM Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.14.3 DSM Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.14.4 DSM Business Overview

3.15 Shandong Lukang Pharmaceutical

3.15.1 Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.15.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.15.4 Shandong Lukang Pharmaceutical Business Overview

3.16 Teva Pharmaceutical

3.16.1 Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.16.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.16.4 Teva Pharmaceutical Business Overview

3.17 Lonza Group

3.17.1 Lonza Group Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.17.3 Lonza Group Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.17.4 Lonza Group Business Overview

3.18 Aurobindo Pharma

3.18.1 Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.18.3 Aurobindo Pharma Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.18.4 Aurobindo Pharma Business Overview

3.19 Pfizer

3.19.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.19.3 Pfizer Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.19.4 Pfizer Business Overview

3.20 GlaxoSmithKline

3.20.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.20.3 GlaxoSmithKline Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.20.4 GlaxoSmithKline Business Overview

3.21 Lupin

3.21.1 Lupin Basic Information, Manufacturing Base, Sales Area and Competitors

3.21.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.21.3 Lupin Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.21.4 Lupin Business Overview

3.22 Hisun Pharmacy

3.22.1 Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors

3.22.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.22.3 Hisun Pharmacy Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.22.4 Hisun Pharmacy Business Overview

3.23 North China Pharmaceutical Group

3.23.1 North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors

3.23.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.23.3 North China Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.23.4 North China Pharmaceutical Group Business Overview

3.24 Novartis International

3.24.1 Novartis International Basic Information, Manufacturing Base, Sales Area and Competitors

3.24.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.24.3 Novartis International Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.24.4 Novartis International Business Overview

3.25 Bayer

3.25.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors

3.25.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification

3.25.3 Bayer Active Pharmaceutical Ingredients Market Performance (2014-2019)

3.25.4 Bayer Business Overview

4 Global Active Pharmaceutical Ingredients Production, Revenue (Value), Price Trend by Type

4.1 Global Active Pharmaceutical Ingredients Production and Market Share by Type (2014-2019)

4.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Type (2014-2019)

4.3 Global Active Pharmaceutical Ingredients Price by Type (2014-2019)

4.4 Global Active Pharmaceutical Ingredients Production Growth Rate by Type (2014-2019)

4.4.1 Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)

4.4.2 Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)

5 Global Active Pharmaceutical Ingredients Market Analysis by Application

5.1 Global Active Pharmaceutical Ingredients Consumption and Market Share by Application (2014-2019)

5.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Oncology (2014-2019)

5.2.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Diabetes (2014-2019)

5.2.3 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Cardiovascular Disease (2014-2019)

5.2.4 Global Active Pharmaceutical Ingredients Consumption Growth Rate of CNS and Neurological Disorders (2014-2019)

5.2.5 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Endocrinology (2014-2019)

5.2.6 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Other (2014-2019)

6 Global Active Pharmaceutical Ingredients Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)

6.2 United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.3 Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.4 China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.5 Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.6 India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

7 Global Active Pharmaceutical Ingredients Production, Revenue (Value) by Region (2014-2019)

7.1 Global Active Pharmaceutical Ingredients Production and Market Share by Region (2014-2019)

7.2 Global Active Pharmaceutical Ingredients Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

8 Active Pharmaceutical Ingredients Manufacturing Analysis

8.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Active Pharmaceutical Ingredients Industrial Chain Analysis

9.2 Raw Materials Sources of Active Pharmaceutical Ingredients Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Active Pharmaceutical Ingredients

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Active Pharmaceutical Ingredients Market Forecast (2019-2026)

11.1 Global Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2026)

11.1.1 Global Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2026)

11.2 Global Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Active Pharmaceutical Ingredients Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Active Pharmaceutical Ingredients Product Picture

Table Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type

Table Profile of Synthetic APIs

Table Profile of Biotech APIs

Table Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Oncology

Table Profile of Diabetes

Table Profile of Cardiovascular Disease

Table Profile of CNS and Neurological Disorders

Table Profile of Endocrinology

Table Profile of Other

Figure Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Poland Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Japan Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure India Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Malaysia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Singapore Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Philippines Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Indonesia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Thailand Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Vietnam Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Central and South America Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Brazil Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Mexico Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Colombia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Turkey Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Egypt Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure South Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Nigeria Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)

Figure Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)

Table Global Active Pharmaceutical Ingredients Production by Player (2014-2019)

Table Global Active Pharmaceutical Ingredients Production Share by Player (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Share by Player in 2018

Table Active Pharmaceutical Ingredients Revenue by Player (2014-2019)

Table Active Pharmaceutical Ingredients Revenue Market Share by Player (2014-2019)

Table Active Pharmaceutical Ingredients Price by Player (2014-2019)

Table Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area by Player

Table Active Pharmaceutical Ingredients Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Johnson & Johnson Profile

Table Johnson & Johnson Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi Profile

Table Sanofi Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Eli Lilly and Company Profile

Table Eli Lilly and Company Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Profile

Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table AbbVie Profile

Table AbbVie Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Haerbin Pharmaceutical Group Profile

Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Shandong Xinhua Pharmaceutical Profile

Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Jiangsu Hengrui Medicine Profile

Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Merck & Co Profile

Table Merck & Co Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Biocon Profile

Table Biocon Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Huahai Pharmaceutical Profile

Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Sun Pharmaceutical Industries Profile

Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table DSM Profile

Table DSM Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Shandong Lukang Pharmaceutical Profile

Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Teva Pharmaceutical Profile

Table Teva Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Lonza Group Profile

Table Lonza Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Aurobindo Pharma Profile

Table Aurobindo Pharma Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Lupin Profile

Table Lupin Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Hisun Pharmacy Profile

Table Hisun Pharmacy Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table North China Pharmaceutical Group Profile

Table North China Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis International Profile

Table Novartis International Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer Profile

Table Bayer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Active Pharmaceutical Ingredients Production by Type (2014-2019)

Table Global Active Pharmaceutical Ingredients Production Market Share by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Market Share by Type in 2018

Table Global Active Pharmaceutical Ingredients Revenue by Type (2014-2019)

Table Global Active Pharmaceutical Ingredients Revenue Market Share by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Type in 2018

Table Active Pharmaceutical Ingredients Price by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption by Application (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of Oncology (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of Diabetes (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of Cardiovascular Disease (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of CNS and Neurological Disorders (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of Endocrinology (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption of Other (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)

Table Global Active Pharmaceutical Ingredients Consumption Market Share by Region (2014-2019)

Table United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)

Table Global Active Pharmaceutical Ingredients Production by Region (2014-2019)

Table Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)

Figure Global Active Pharmaceutical Ingredients Production Market Share by Region in 2018

Table Global Active Pharmaceutical Ingredients Revenue by Region (2014-2019)

Table Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)

Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)

Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region in 2018

Table Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

Table India Active Pharmaceutical Ingredien

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370